NGM Biopharmaceuticals In... (NGM)
NASDAQ: NGM
· Real-Time Price · USD
1.54
-0.02 (-1.28%)
At close: Apr 03, 2024, 3:59 PM
NGM Biopharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -27.67M | -28.8M | -38.26M | -47.65M | -36.44M | -47.26M | -46.52M | -32.45M | -27.23M | -28.86M | -36.69M | -27.54M |
Depreciation & Amortization | 518K | 535K | 559K | 609K | 614K | 598K | 1.4M | 1.43M | 1.48M | 1.49M | 1.56M | 1.55M |
Stock-Based Compensation | 6.3M | 6.41M | 7.48M | 8.54M | 8.77M | 7.69M | 8.1M | 7.82M | 6.58M | 6.37M | 6.72M | 6.58M |
Other Working Capital | -7.29M | -3.55M | -2.39M | -7.69M | -7.92M | 13.48M | -15.92M | -13.56M | -165K | 8.15M | 1.58M | -944K |
Other Non-Cash Items | 8.63M | 554K | 1.02M | -477K | -322K | 660K | 731K | 1.45M | 2.42M | -20K | 4.96M | -315K |
Deferred Income Tax | -9.18M | -1.38M | -1.56M | n/a | n/a | n/a | n/a | n/a | 968K | 1.03M | 948K | 570K |
Change in Working Capital | -1.56M | -4.48M | -9.49M | -2.85M | -3.03M | 10.17M | -13.86M | -13.99M | -2.55M | 10.64M | -810K | -3.07M |
Operating Cash Flow | -22.96M | -27.16M | -40.25M | -41.83M | -30.4M | -28.15M | -50.15M | -35.74M | -18.34M | -9.36M | -23.31M | -22.23M |
Capital Expenditures | -188K | -290K | -104K | -670K | -441K | -310K | -822K | -285K | -133K | -196K | -1.2M | -160K |
Cash Acquisitions | 88.16M | -27.16M | -24.69M | -36.31M | -2.13M | -35.76M | 15.14M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -33.62M | -22.64M | -34.71M | -14.46M | -100.37M | -28.44M | -57.14M | -86.9M | -98.94M | n/a | -49.53M | -145M |
Sales Maturities Of Investments | 61M | 49.8M | 59.4M | 50.77M | 102.5M | 64.2M | 42M | 80.34M | 121M | 52.5M | 22M | 28M |
Other Investing Acitivies | -88.16M | 27.16M | 24.69M | 36.31M | 2.13M | 35.76M | -15.14M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 27.19M | 26.87M | 24.59M | 35.64M | 1.69M | 35.45M | -15.97M | -6.85M | 21.93M | 52.3M | -28.72M | -117.16M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 111K | n/a | 1.39M | 279K | 723K | 33.22M | 19.62M | 668K | 2.38M | 3.48M | 3.32M | 140.48M |
Financial Cash Flow | 111K | n/a | 1.39M | 279K | 723K | 33.22M | 19.62M | 668K | 2.38M | 3.48M | 3.32M | 140.48M |
Net Cash Flow | 4.34M | -295K | -14.28M | -5.91M | -27.99M | 40.52M | -46.49M | -41.92M | 5.97M | 46.42M | -48.71M | 1.1M |
Free Cash Flow | -23.15M | -27.45M | -40.35M | -42.5M | -30.84M | -28.46M | -50.97M | -36.02M | -18.47M | -9.55M | -24.5M | -22.39M |